Ingredion Q2 adjusted EPS $2.82, reaffirms guidance; Tate & Lyle acquisition approved

Ingredion Inc

Q2 reported EPS $1.78, adjusted EPS $2.82; reported operating income down 31%, adjusted down 5% vs Q2 2025.
Reaffirming full-year guidance: reported EPS $9.15-$9.75, adjusted EPS $10.30-$10.90.
Texture & Healthful Solutions delivered 9th consecutive quarter of net sales volume growth.
Ingredion's 595 pence all-cash offer for Tate & Lyle accepted by their shareholders on July 28.
Argo plant operating at normal production rates across all major units after reliability improvements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.